Visconti and colleagues give further support to these results, as their study showed that healthy subjects and patients suffering from osteoarthritis and osteoporosis, are characterised by different PTX3 serum levels, again suggesting the involvement of this molecule in bone metabolism and how it may represent a new potential marker for bone-related phenotypes [18]. This evidence concerns the gene PTX3 and osteoporosis.